2022. Persistent Supravenous Erythematous Eruption (PSEE): A scoping review on an adverse effect related to Docetaxel infusion. Research, Society and Development. 11, 5 (Apr. 2022), e21111527974. DOI:https://doi.org/10.33448/rsd-v11i5.27974.